Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
Background. Hypocalcaemia is increasingly recognized as a complication of denosumab use in Chronic Kidney Disease (CKD) patients with osteoporosis. Despite Therapeutic Goods Administration (TGA) notifications in 2013, we have subsequently encountered several cases of denosumab-induced hypocalcaemia,...
| मुख्य लेखकों: | , , , |
|---|---|
| स्वरूप: | लेख |
| भाषा: | English |
| प्रकाशित: |
Wiley
2018-01-01
|
| श्रृंखला: | Case Reports in Nephrology |
| ऑनलाइन पहुंच: | http://dx.doi.org/10.1155/2018/7384763 |